We're committed to clinical research
Sidekick's digital health solutions are clinically-validated and evidence-based. Our scientific research is published in leading healthcare conferences and peer-reviewed journals.
Here are our publications in these therapeutic areas
Immunology and Inflammation
Clinical Efficacy of a Digital Intervention for Patients with Atopic Dermatitis: a Prospective Single Center Study
Dermatology and Therapy. 2022;12:2601–11.
Gudmundsdóttir SL, Ballarini T, Ámundadóttir ML, Mészáros J, Eysteinsdóttir JH, Thorleifsdóttir RH, Hrafnkelsdóttir SK, Bragadóttir HB, Oddsson S, Silverberg JI
A21 A digital treatment support program for RA and PsA patients in a real-world setting. High patient engagement and improved energy levels.
Reuma Bulletin, 2021;147(4):29. Abstracts of eReumadagarna, Stockholm, Sweden. September 16-17, 2021.
Oddsson S, Loftsson K, Ámundadóttir ML, Ylänne K, Helgadóttir H, Thorgeirsson T.
P376 Improving Stress and Fatigue in a real-world setting among patients with Inflammatory Bowel Disease through a digital platform.
Journal of Crohn's and Colitis, 2021; 15(Suppl1): S391–S392. Abstracts of the 16th Congress of ECCO Virtual, July 2-3 & 8-10, 2021.
Oddsson S, Gunnarsdottir T, Johannsdottir L, Amundadottir ML, Frimannsdottir A, Ylanne K, Molander P, Islind A, Oskarsdottir M, Thorgeirsson T.
P487 The Feasibility of a Digital Platform for Improving Disease Management Among Patients With Ulcerative Colitis.
Journal of Crohn's and Colitis, 2021; 15(Suppl1): S474. Abstracts of the 16th Congress of ECCO Virtual, July 2-3 & 8-10, 2021
Oddsson S., Gunnarsdottir T, Ylanne, K, Molander P, Thorgeirsson T.
A Digital Therapeutic Solution for Atopic Dermatitis; Protocol for a Nonrandomized, Single-Arm, Interventional Trial.
Br J Dermatol, 2022;186: e135-e173. Revolutionizing Atopic Dermatitis, 11–13 December 2021.
Gudmundsdottir SL, Eysteinsdottir J, Þorleifsdottir RH, Ulfsdottir H, Reykdal E, Hrafnkelsdottir SK, Bragadottir HB, Oddsson S, Silverberg J.
A Novel Digital Therapeutic Intervention to Improve Symptoms of Atopic Dermatitis: a Feasibility Study
Br J Dermatol, 2022; 187: e80-e133. Revolutionizing Atopic Dermatitis, 9–11 April 2022.
Gudmundsdottir SL, Ballarini T, Ámundadóttir ML, Mészáros J, Eysteinsdottir JH, Thorleifsdottir RH, Ulfsdottir H, Hrafnkelsdottir SK, Bragadottir HB, Helgadottir H, Oddsson S, Silverberg J.
A Digital Therapeutic Intervention for Breast Cancer Patients During Active Treatment: A Feasibility Study
Annals of Oncology, Volume 33, S230. Abstract Book of ESMO Breast Cancer 2022, Berlin, Germany, 03-05 May 2022
G. E. Thorvardardottir, H. Gudmundsson, J. Mészáros, A.E. Bjornsdottir, M.L. Amundadottir, O.K. Bjarnadottir, E. Magnusdottir, H. Helgadottir, S. Oddson
Improving outpatient care for heart failure through digital innovation: a feasibility study.
Pilot and Feasibility Studies. 2022;8:242
Arnar DO, Oddsson SJ, Gunnarsdottir T, Gudlaugsdottir GJ, Gudmundsson EF, Ketilsdóttir A, Halldorsdottir H, Hrafnkelsdottir TJ, Hallsson H, Amundadottir ML, Thorgeirsson T
Improving outpatient care and symptoms for heart failure patients through digital innovation: a feasibility study.
European Journal of Heart Failure. 2021;23(Suppl S2):119. Abstracts of the Heart Failure 2021 and the World Congress on Acute Heart Failure, Online. 29 June - 1 July 2021
Arnar DO, Oddsson SJ, Gunnarsdottir T, Gudlaugsdottir GJ, Ketilsdottir A, Hrafnkelsdottir TJ, Halldorsdottir H, Amundadottir ML, Hallsson H, Thorgeirsson T.
A Novel Digital Therapeutic Program is Feasible for Patients with Peripheral Artery Disease.
Circulation, 2022;145(Suppl1):AP044. Abstracts of the American Heart Association Epidemiology and Prevention, Lifestyle and Cardiometabolic Health conference. Chicago IL. March 1-4, 2022
Oddsson SJ, Wahlgren CM, Nordanstig J, Gottsäter A, Gunnarsdottir T, Ulfsdottir H, Gudmundsson EF, Bjornsdottir AE, Thorgeirsson T.
A Digital Therapeutic Intervention is Feasible for Outpatient Care in Coronary Artery Disease.
Circulation, 2022;145(Suppl1):AP049. Abstracts of the American Heart Association Epidemiology and Prevention, Lifestyle and Cardiometabolic Health conference, Chicago IL. March 1-4, 2022
Arnar DO, Oddsson SJ, Gunnarsdottir T, Olafsdottir IV, Guömundsdottir MV, Loftsson KH, Gudmundsson EF, Kaernested B, Amundadottir ML, Sigurdardottir S, Mogensen B, Libungan B, Thorgeirsson T.
Reduced Liver Fat and Improved Cardiometabolic Health in Individuals With Non Alcoholic Fatty Liver Disease After a 12 Week Digital Intervention - A Feasibility Study
Presented at EPI|Lifestyle 2023
Bjornsdottir S, Ulfsdottir H, Gudmundsson EF, Sveinsdottir K, Isberg AP, Bjornsdottir G, Sigurdsson S, Oddsson S, Gudnason V
Effects of a Gamified Mobile Application to Support a Lifestyle-Change Program in Adults: A Controlled Pilot.
Diabetes, 2017;66(Supplement_1):A42. Abstract presented at the American Diabetes Association’s 77th Scientific Sessions, 9-13 June 2017, San Diego, CA.
See also https://www.medscape.com/viewarticle/882130 for a brief coverage on study findings by Medscape.
Randomized Trial for Weight Loss Using a Digital Therapeutic Application.
Journal of Diabetes Science and Technology. March 2021. doi:10.1177/19322968211000815 Epub ahead of print. PMID: 33736484.
Thorgeirsson T, Torfadottir JE, Egilsson E, Oddsson SJ, Gunnarsdottir T, Aspelund T, Olafsdottir AS, Valdimarsdottir UA, Kawachi I, Adami H, Bjarnason RG.
Have a question?
To contact us about our clinical outcomes, send an email to: